Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial
Diana Rubel(Australian National University), Stephen Shumack(Royal North Shore Hospital), Lynda Spelman(Veracity Clinical Research), Hans Christian Wulf(Bispebjerg Hospital), Delphine Kérob(Galderma (France)), Peter Foley(The University of Melbourne), Nabil Kerrouche(Galderma (France)), D. Brock Hewitt(New York University), Catherine Bosc(Galderma (France)), Jo‐Ann See, Dédée F. Murrell(Sutherland Hospital)
Cited by 221
Related Papers
Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification
|Journal of the American Academy of Dermatology|2014|933
The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB
|Journal of the American Academy of Dermatology|2008|933
Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility
|British Journal of Dermatology|2020|778
Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus
|Journal of the American Academy of Dermatology|2006|654